Journal
JOURNAL OF PAIN RESEARCH
Volume 16, Issue -, Pages 1243-1255Publisher
DOVE MEDICAL PRESS LTD
DOI: 10.2147/JPR.S406714
Keywords
arthralgia; chronic pain; zygapophyseal joint; pain management; radiofrequency ablation; neuromodulation; lumbar facet joint
Categories
Ask authors/readers for more resources
This study evaluated the efficacy and feasibility of radiofrequency ablation (RFA) using V-shaped active tip needles for chronic lumbar zygapophyseal joint dysfunction. The results showed significant improvements in NRS, DN4, EQ-index, and EQ-5D-VAS at different time points. Therefore, RFA may be a feasible and effective treatment for chronic lumbar zygapophyseal joint pain.
Background: Lumbar zygapophyseal joint dysfunction represents one of the major sources of chronic low back pain. Radiofrequency ablation (RFA) using a V-shaped active tip needle may offer a larger lesion of the medial branch nerves, improving clinical outcome. The aim of our study is to evaluate the efficacy and the feasibility of RFA using V-shaped active tip needles. Methods: This is a single-center observational retrospective study. Clinical records were screened and analyzed if they met the following inclusion criteria: adult patients (>18 years), diagnosis of chronic lumbar zygapophyseal joint pain, failure of conservative treatments, ability to provide informed consent for data analysis and publication. Exclusion criteria: lumbar pain not related to zygapophyseal joints, previous spinal/lumbar surgery, incomplete data, absence or withdrawal of informed consent. The primary outcome of the study was a change in pain intensity at follow-up. The secondary outcomes were the evaluation of quality-of-life improvement, the occurrence of adverse events and the impact on post-procedural analgesic consumption. For these purposes, pre-and post-treatment numeric rating scale (NRS), neuropathic pain 4 questions (DN4), EuroQoL -EQ-5D-3L, EQ-VAS, EQ-index and North American Spine Society (NASS) index were retrieved and analysed. Results: Sixty-four patients were included. 7.8% of patients at 1-month (CI95% 0.026, 0.173), 37.5% at 3-month (CI95% 0.257, 0.505), 40.6% at 6-month (CI95% 0.285, 0.536) and 35.9% at 9-month (CI95% 0.243, 0.489) follow-up reported a reduction of more than 80% in NRS Statistical analysis indicated a significant change in NRS, DN4, EQ-index and EQ-5D-VAS (p-value <0.001) at the different time-points. Conclusion: RFA using a V-shaped active tip needle might be a feasible and effective treatment for chronic lumbar zygapophyseal joint pain.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available